Company / Depreciation & Amortization
aTYR PHARMA INC Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$664.0K
FY2025
5-year range
$475.0K / $708.0K
FY2021-FY2025
Trend
-6.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 7 years, ranging from $475,000 in FY2023 to $746,000 in FY2020.
Based on SEC 10-K filings.
$664,000 in FY2025 with a 5-year CAGR of -2.3%.
Increased from $475,000 to $664,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- -2.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.3%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 6.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
- Lowest depreciation & amortization in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $664.0K | -6.2% |
| FY2024 | $708.0K | +49.1% |
| FY2023 | $475.0K | -16.5% |
| FY2022 | $569.0K | -10.4% |
| FY2021 | $635.0K | -14.9% |
| FY2020 | $746.0K | +4.6% |
| FY2019 | $713.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026